Company intelligence / Profile preview

Oxford Vacmedix

Oxford, England, United Kingdomoxfordvacmedix.com ↗

Ownership: Private
Employees: ~10
Development stage: Phase 1

Overview

Oxford Vacmedix has developed a proprietary ROP immunotherapy platform with two lead vaccine candidates—OVM–100 for cervical cancer and OVM–200 for survivin-expressing solid tumors. Both are being advanced toward clinical trials as monotherapies and in combination with immune-oncology agents. The company also has a diagnostic program for anti-microbial resistance. As of the latest information, no active clinical trials are registered on ClinicalTrials.gov.

Therapeutic areas: OncologyInfectious Diseases
Modalities: Therapeutic cancer vaccines (immunotherapy)Diagnostics (for cancer and infectious diseases)Recombinant Overlapping Peptides (ROP) platform
Industry: Biotech

Drug pipeline

6 assets

ovm-200

5 more assets in the full pipeline.

Request access →

Partnerships

Changzhou Bioscience Group/CBIG in China for diagnostics development using ROP technologyseeking pharma partners for co-development and NHS hospitals for clinical trial participationInnovate UK partnership grant awarded.

Beyond the preview

Go deeper on Oxford Vacmedix.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Oxford Vacmedix.

Explore the full profile